OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The landscape of genetic alterations in ameloblastomas relates to clinical features
Sibel Elif Gültekin, Reem Aziz, Carina Heydt, et al.
Virchows Archiv (2018) Vol. 472, Iss. 5, pp. 807-814
Open Access | Times Cited: 70

Showing 26-50 of 70 citing articles:

Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors
Svenja Wagener‐Ryczek, Carina Heydt, Juliane Süptitz, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 27

Genetic factors in the pathogenesis of ameloblastoma, dentigerous cyst and odontogenic keratocyst
Soudeh Ghafouri‐Fard, Saede Atarbashi‐Moghadam, Mohammad Taheri
Gene (2020) Vol. 771, pp. 145369-145369
Closed Access | Times Cited: 25

The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma
Luvy Delfin Mendez, Nicholas S. Wolsefer, L. Sylvia, et al.
Modern Pathology (2022) Vol. 35, Iss. 11, pp. 1570-1577
Open Access | Times Cited: 15

An immunohistochemical and genetic study of BRAFV600E mutation in Japanese patients with ameloblastoma
Mai Seki, Takaaki Sano, Kenta Ito, et al.
Pathology International (2020) Vol. 70, Iss. 4, pp. 224-230
Closed Access | Times Cited: 23

Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations
Abbas Agaimy, Alena Skálová, Alessandro Franchi, et al.
Histopathology (2020) Vol. 76, Iss. 6, pp. 814-821
Open Access | Times Cited: 22

Factors Associated with Recurrence of Ameloblastoma: A Scoping Review
Pornnutcha Inthong, Witsarut Upalananda, Jirayu Saepoo
Head and Neck Pathology (2024) Vol. 18, Iss. 1
Closed Access | Times Cited: 2

LGR5+ epithelial tumor stem-like cells generate a 3D-organoid model for ameloblastoma
Ting-Han Chang, Rabie M. Shanti, Yanfang Liang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 20

High frequency of BRAF V600E mutation in Iranian population ameloblastomas
Samira Derakhshan, Pouyan Aminishakib, Abbas Karimi, et al.
Medicina oral, patología oral y cirugía bucal (2020), pp. e502-e507
Open Access | Times Cited: 19

Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis
Lucrezia Togni, Antonio Zizzi, Roberta Mazzucchelli, et al.
International Journal of Oral Science (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 11

Anti-MAPK Targeted Therapy for Ameloblastoma: Case Report with a Systematic Review
Anton Raemy, Laurence May, Nathalie Sala, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2174-2174
Open Access | Times Cited: 2

Molecular biology exploration and targeted therapy strategy of Ameloblastoma
Yiwen Lu, Xudong Zhang, Xiangjun Li
Archives of Oral Biology (2022) Vol. 140, pp. 105454-105454
Open Access | Times Cited: 10

Genomic profiling and precision medicine in complex ameloblastoma
James C. Gates, Allison Clark, Elliot Cherkas, et al.
Head & Neck (2023) Vol. 45, Iss. 4, pp. 816-826
Closed Access | Times Cited: 6

Identification of circ_0089153/miR‐608/EGFR p53 axis in ameloblastoma via MAPK signaling pathway
Jinwen Liu, Xue Qiao, Jiayi Liu, et al.
Oral Diseases (2021) Vol. 28, Iss. 3, pp. 756-770
Closed Access | Times Cited: 13

Genetic Study of BRAF V600E and SMO L412F Mutations in Japanese Patients with Ameloblastoma
Katsutoshi Kokubun, Kei Yamamoto, Yoshihiko Akashi, et al.
International Journal of Surgical Pathology (2022) Vol. 30, Iss. 4, pp. 378-384
Closed Access | Times Cited: 9

A review of the molecular profile of benign and malignant odontogenic lesions
Filipe Fideles Duarte‐Andrade, Jéssica Gardone Vitório, Thaís dos Santos Fontes Pereira, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2020) Vol. 129, Iss. 4, pp. 357-368
Closed Access | Times Cited: 14

DNA damage and repair scenario in ameloblastoma
Sneh M. Toprani
Oral Oncology (2020) Vol. 108, pp. 104804-104804
Closed Access | Times Cited: 14

Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres
Riccardo Bonacina, Alice Indini, Gabriella Massazza, et al.
Journal of Clinical Pathology (2021) Vol. 75, Iss. 8, pp. 555-559
Closed Access | Times Cited: 12

Molecular diagnostics in odontogenic tumors
Reinhard Buettner, Sibel Elif Gültekin
Deleted Journal (2022) Vol. 43, Iss. S1, pp. 81-85
Open Access | Times Cited: 8

Conservative management is effective in unicystic ameloblastoma occurring from the neonatal period: A case report and a literature review
Anne Morice, Cécilia Neiva, Monique Fabrè, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2019) Vol. 129, Iss. 5, pp. e234-e242
Closed Access | Times Cited: 13

Conceptual changes in ameloblastoma: Suggested re‐classification of a "veteran" tumor
Ayelet Zlotogorski‐Hurvitz, Merva Soluk Tekkeşin, Fabrício Passador‐Santos, et al.
Oral Diseases (2021) Vol. 28, Iss. 3, pp. 703-710
Open Access | Times Cited: 9

Alteration of primary cilia morphology and associated signalling in ameloblastoma
Jana Filušová, Iveta Putnová, Pavel Hurník, et al.
Archives of Oral Biology (2022) Vol. 142, pp. 105499-105499
Open Access | Times Cited: 6

Genetic Profile of Adenomatoid Odontogenic Tumor and Ameloblastoma. A Systematic Review
Constanza Celia Nieto Marín, Sven Niklander, Rene Flores
Frontiers in Oral Health (2021) Vol. 2
Open Access | Times Cited: 8

Targeting BRD4 attenuates the stemness and aggressiveness of ameloblastoma
Jiaxiang Xie, Jingqi Zhang, Gan Xiong, et al.
Oral Diseases (2023) Vol. 30, Iss. 5, pp. 3212-3224
Closed Access | Times Cited: 3

The Role of BRAF Inhibitors in the Management of Ameloblastoma: A Literature Review
Arindam Malakar, Vivek Kumar, Priya Yadav, et al.
Cureus (2023)
Open Access | Times Cited: 3

Pediatric Odontogenic Tumors
Yingci Liu, Molly Housley Smith, Paras Patel, et al.
Pediatric and Developmental Pathology (2023) Vol. 26, Iss. 6, pp. 583-595
Closed Access | Times Cited: 3

Scroll to top